Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs

Pranesh MIGAM; Ram D. MUKHIJA; Arun K. GUPTA; Sat G. DAYAL; Brij M. GOYAL

doi:10.47878/hi.1984.v9.35571

Autores/as

Pranesh MIGAM Readerin Medicine.
Ram D. MUKHIJA Professor of skin, V.D. and leprosy
Arun K. GUPTA Professor of Medicine—Baba Raghav Das Medical College, Gorakhpar-273013, India.
Sat G. DAYAL Skin,V.D. and leprosy specialist—Mahayei GeneralHospital, Mahayel (Abha) Aseer, KingdomofSaudi Arabia
Brij M. GOYAL Reader in tuberculosis and chest diseases—Mahaan1 Laksluni Bai Medical College, Jhansi-284128, India.

DOI:

https://doi.org/10.47878/hi.1984.v9.35571

Palabras clave:

Gonads, Gynaecomastia, Testicle, Epididymes, Hanseniasis, Leprosy, Indigenous drugs

Resumen

Sixty male patients of leprosy (mean age = 27.2+5.04 years) selected at random, were studied for gonadal involvement and therapeutic efficacy of two indigenous drugs. Of these 34 were married, with the mean duration of illness 4.17+3.27 years. Only those with lepromatous and dimorphous leprosy developed testicular and epididymal changes. Testicular pain and/or swelling (lepromatous =62.5%, dimorphous 30%) was the commonest presenting feature. Altered sexual function was observed in 34 (56.6%) cases, while 11 patients revealed altered sexual hair pattern and nine gynaeco-mastia. Reduced testicular size associated with soft feel was present in 25% of cases with no testicular sensation in 8 (13.3%) and impaired testicular sensation in 9 (15%) patients. Spermogram revealed azoospermia in 19 (35%) and oligospermia in 16 (26.6%) patients. Histopathological findings of testicle biopsy revealed evidence of leprous pathology irrespective of testicular size, semen picture and clinical manifestations. Histopatho-logical changes had shown marked variation and so did not enable categorising them into vascular, interstitial and obliterative phases. These changes were believed to be due to the altered gonadal state in leprosy. The therapeutic efficacy of the indigenous preparations, Speman and Tentex forte (Himalaya) was evaluated subjectively as well as objectively in 34 patients. 823% of cases showed subjective improvement while objective improvement in spermogram was noted in 87.5% cases with oligospermia. The drugs have no side effect and were well tolerated.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. BERNARD,J.C.&VAZQUEZ,C.A.J.Visceral lesions in lepromatous leprosy: study of sixty necropsies. Int. J. Lepr., 41 (l): 94-101, 1973.
2. CAMERON, C.B. Urinary excretion of oestrone, oestradiol-17B and oestriol in patients with chronic liver damage. J. Endocr., 15 (2):
199-205, 1957.
3. CLINICAL, histopathological and immunological features of the five-type classi-fication approved by the Indian Association of Leprologists. Lepr. India, 54 (l): 22-25, 1982.
4. THE CONSENSUS classification of leprosy approved by the Indian Association of Leprologists. Lepr. India, 54 (l): 17 - 21, 1982.
5. DAVEY, T.F. & SCHENCK, R.R. The endocrines in leprosy. In: COCHRANE, R.G. & DAVEY, T.F., ed. Leprosy in theory and practice. 2. ed. Bristol, John Wright, 1964. p. 190-204.
6. DESIKAN, K.V. & JOB, C.K. Visceral le-sions caused by M. leprae: a histopa-thological study. Indian J. Path. Bact., 13: 100-108, 1970.
7. DHARMENDRA. Classification of leprosy. Editorial. Lepr. India, 54 (l): 8-16, 1982.
8. EL-SHIEMY, S.; EL-HEFNAWI, H.; ABDEL-FATTAH, A.; EL-OKBI. M; FARE, A. Testicular and epididymal involvement in leprosy patients, with special reference to gynecomastia.Int. J. Derm., 15 (l): 52-58, 1976.
9. GRABSTALD, H.& SWAN, L.L. Genitourinary lesions in leprosy with special reference to the problem of atrophy of the tests. J. Amer. Med. Ass.,149 (14): 1287-1291, 1952.
10. GROLLMAN, A. Clinical endocrinology and its physiological basis. Philadelphia, J.B. Lippincott, 1964. 442p., íl.
11. JADHAV, S.S. & BAHGA, H.S. Effect of Tentex forte and Speman individually and in combination on gonadal structure in rats. J. Ind. Med. Prof. 17: 8055-8062,1971.
12. JAYATILAK, P.G.; SHETH, A.R.; PALLAVI, P.; MUGATWALA, PP.; PARDANANI, D.S. Effect of an indigenous drug Speman on human accessory reproductive function. Indian J. Surg., 1: 12-20, 1976.
13. JOB, C.K. & MACADEN, V.P. Leprous orchitis in reactional bordeline cases. Int. J. Lepr., 31 (3): 273-279, 1963.
14. KUMAR, B.; RAINA, A; KAUR, S.; DASH, RJ.; SAMUEL, E.; DATTA, B. N. Clinicopathological study of testicular involvment in leprosy. Lepr. India, 54 (l): 48-55, 1982.
15. MARDIKAR, B.R. A preliminary report on clinical trials with Tentex forte and Speman. Probe, 15 (l): 8-14, 1975.
17. MITSUDA, K. Atlas of leprosy. Okayama, Chotokai Foundation, 1952. 80p. (Papers of leprosy, v. 6).
18. NIGAM. P.; DAYAL, S.G.; GOYAL, B.M.; NIMKHEDAKAR, K.V.; JOSHI, L.D.; SAMUEL, K.C. Leprous hepatitis: clinico-pathological study and therapeutic efficacy of LIV 52. Lepr. India, 50 (2): 185-195, 1978.
19. NIGAM, P.; MUKHIJA, R.D.; GOYAL, B. M.; JOSHI, L.D.; SAMUEL, K.C. Study of histo-functional complex of liver in leprosy. Indian J. Derm. Venereol. Leprol., 42 (5): 217-222, 1976.
20. PARDANANI, D.S.; DELIMA, RJ.; RAO, R.V.; VAZE, A.Y.; JAYATILAK, P. G.; SHETH, A.R. Study of the effects of Speman on semem quality in oligospermic men. Indian J. Surg., 1: 3440, 1976.
20. RAJASEKHARAN, A. Studies on Speman and Speman-tentex forte combination in male infertility. Probe, 18 (3): 171-172, 1979.